glp-1 receptor agonist fatigue management strategies Ten Top Tips for the of Agonists in Adults within Primary Care Have you heard about GLP‑1

Therapists will need to be dynamic in their practice, enabling them to provide comprehensive care that integrates medication and lifestyle change for sustained health improvements

Nausea was more frequent with tirzepatide vs placebo, especially with tirzepatide 15 mg (OR 5.60 [95% CI 3.12, 10.06]), associated with higher incidence of vomiting (OR 5.50 [95% CI 2.40, 12.59]) and diarrhoea (OR 3.31 [95% CI 1.40, 7.85])

The news: One in five employers cover GLP-1 drugs for weight loss in 2025, with larger employers more likely to cover these medications, per KFFs latest Employer Health Benefits survey

[DOI] [PMC free article] [PubMed] [Google Scholar] 232.Teixeira LCR, et al

No, current UK guidance advises against using GLP-1 receptor agonists during breastfeeding due to insufficient safety data on excretion into breast milk and potential effects on nursing infants

[DOI] [PubMed] [Google Scholar] 323.Brubaker P.L